BASAFEN

This brand name is authorized in Nigeria.

Active ingredients

The drug BASAFEN contains one active pharmaceutical ingredient (API):

1	Ibuprofen UNII WK2XYI10QM - IBUPROFEN
	Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
	Read more about Ibuprofen

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-1167	Suspension	Basafen suspension SUSP 100 mg/5 mL 100 mL (in amber-colored PET bottle)	A peach vicious in non-setting suspension with cherry flavor in 100 mL amber PET bottle with plifer proof cap and graduated measuring cup atop 6/8/2024 19:53:15 Basafen suspension Ibuprofen A11-1167 Oral Suspension Oral Ibuprofen Each 5ml contains 100mg 100ml OTC Biomedical Ltd 1, Ohimege street Industrial Estate Gaa-Imam Ilorin Biomedical Ltd 1, Ohimege street Industrial Estate Gaa-Imam Ilorin Nigeria 21/09/2020 20/08/2020 Yes M01AE01	21/09/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE01	Ibuprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-1167